RecruitingNot ApplicableNCT06434831

Evaluation of Autonomic Nervous System Changes in Response to Stimulation by Sacral Neuromodulation


Sponsor

University Hospital, Lille

Enrollment

40 participants

Start Date

Feb 14, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Overactive bladder syndrome (OAB) is defined by urgent and frequent urges to urinate associated with frequent night-time urination and sometimes urinary incontinence. Sacral neuromodulation (SNM) is now one of the second-line treatments for OAB. The mode of action of SNM is still poorly understood but a number of data from recent scientific literature suggest that SNM may act, among other things, by altering the balance of the autonomic nervous system (ANS) - located at the interface between the urinary tract and the brain structures regulating the functioning of the urinary tract. The aim of this study would therefore be to develop a predictive tool for the effectiveness of SNM.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Medical device for SNM: Interstim X or Interstim micro for people with bladder hyperactivity and sacral neuromodulation. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMedical device for SNM: Interstim X or Interstim micro

ANI will be used during the SNM (2 hours)


Locations(1)

chu de Lille

Lille, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06434831


Related Trials